Abstract Lipoprotein (a), or Lp (a), is structurally like low‐density lipoprotein (LDL) but differs
in that it contains glycoprotein apolipoprotein (a)[apo (a)]. Due to its prothrombotic and …

Abstract Background Lipoprotein (a)[Lp (a)] is one of the residual risk factors for
cardiovascular disease (CVD) in the setting of optimal low-density lipoprotein cholesterol …

Lipoprotein (a) is a complex lipoprotein with unique characteristics distinguishing it from all
the other apolipoprotein B-containing lipoprotein particles. Its lipid composition and the …

Lipoprotein (a)(Lp (a)) is an established risk factor for multiple cardiovascular diseases.
Several lines of evidence including mechanistic, epidemiologic, and genetic studies support …

Atherosclerotic plaque results from a complex interplay between lipid deposition,
inflammatory changes, cell migration and arterial wall injury. Over the past two decades …

Purpose High plasma concentrations of LDL and lipoprotein (a)(Lp [a]) are independent and
causal risk factors for atherosclerotic cardiovascular disease (ASCVD). There is an unmet …

An elevated level of lipoprotein (a)[Lp (a)] is a genetically regulated, independent, causal
risk factor for cardiovascular disease. However, the extensive variability in Lp (a) levels …

Carotid artery stenosis (CAS), an atherosclerotic disease of the carotid artery, is one of the
leading causes of transient ischemic attacks (TIA) and cerebrovascular attacks (CVA). The …

Background: Whether trends in insulin resistance changes are related to the risk of
cardiovascular disease (CVD) incidence and mortality remains unclear. We aimed to …

Cardiovascular disease (CVD) is still a leading cause of morbidity and mortality, despite all
the progress achieved as regards to both prevention and treatment. Having high levels of …